Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lodi Hospital, Lodi, Italy
Researchers from Italy and the United States report details of new studies and findings in the area of breast cancer
September 13th, 2006
Breast cancer data are the focus of recent research from Italy and the United States. Study 1: Tamoxifen-treated breast cancer may influence the progression of atypical endometrial lesions. Researchers in Italy report, "The purpose of the present study is to prospectively evaluate the effects of tamoxifen on the pathological behavior of endometrial hyperplasias without atypia, diagnosed before the start of adjuvant endocrine therapy, in menopausal patients suffering from breast cancer." "Twenty-six patients suffering from estrogen-receptor positive breast cancer and candidate to receive adjuvant tamoxifen, were found to be...
Source: Telemedicine Business Week (2006-09-13)
|
